Global Nintedanib Market Growth 2025-2031
The global Nintedanib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Nintedanib is an oral medication used for the treatment of idiopathic pulmonary fibrosis (IPF) and some types of non-small-cell lung cancer (NSCLC). It is a tyrosine kinase inhibitor (TKI), which blocks enzymes in cells in the lungs called tyrosine kinases. Blocking these enzymes helps decrease fibrous tissue forming in the lungs and so stops the symptoms of lung disease getting worse.
The future market trends of Nintedanib are expected to be influenced by the following factors:The increasing prevalence of IPF and NSCLC, especially among the elderly population, and the rising awareness and diagnosis of these diseases.The growing research and development activities in fibrotic and oncologic diseases, and the emergence of new drugs and formulations that may offer better efficacy and safety than Nintedanib.The expansion of the market in emerging regions, such as Asia-Pacific and Latin America, where Nintedanib has been approved or is under review by regulatory authorities.The impact of the COVID-19 pandemic, which may increase the risk of IPF and NSCLC among patients who have recovered from the infection, and also pose challenges for the supply chain and distribution of Nintedanib.
LP Information, Inc. (LPI) ' newest research report, the “Nintedanib Industry Forecast” looks at past sales and reviews total world Nintedanib sales in 2024, providing a comprehensive analysis by region and market sector of projected Nintedanib sales for 2025 through 2031. With Nintedanib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nintedanib industry.
This Insight Report provides a comprehensive analysis of the global Nintedanib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nintedanib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nintedanib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nintedanib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nintedanib.
This report presents a comprehensive overview, market shares, and growth opportunities of Nintedanib market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Nintedanib market?
What factors are driving Nintedanib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nintedanib market opportunities vary by end market size?
How does Nintedanib break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Nintedanib is an oral medication used for the treatment of idiopathic pulmonary fibrosis (IPF) and some types of non-small-cell lung cancer (NSCLC). It is a tyrosine kinase inhibitor (TKI), which blocks enzymes in cells in the lungs called tyrosine kinases. Blocking these enzymes helps decrease fibrous tissue forming in the lungs and so stops the symptoms of lung disease getting worse.
The future market trends of Nintedanib are expected to be influenced by the following factors:The increasing prevalence of IPF and NSCLC, especially among the elderly population, and the rising awareness and diagnosis of these diseases.The growing research and development activities in fibrotic and oncologic diseases, and the emergence of new drugs and formulations that may offer better efficacy and safety than Nintedanib.The expansion of the market in emerging regions, such as Asia-Pacific and Latin America, where Nintedanib has been approved or is under review by regulatory authorities.The impact of the COVID-19 pandemic, which may increase the risk of IPF and NSCLC among patients who have recovered from the infection, and also pose challenges for the supply chain and distribution of Nintedanib.
LP Information, Inc. (LPI) ' newest research report, the “Nintedanib Industry Forecast” looks at past sales and reviews total world Nintedanib sales in 2024, providing a comprehensive analysis by region and market sector of projected Nintedanib sales for 2025 through 2031. With Nintedanib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nintedanib industry.
This Insight Report provides a comprehensive analysis of the global Nintedanib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nintedanib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nintedanib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nintedanib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nintedanib.
This report presents a comprehensive overview, market shares, and growth opportunities of Nintedanib market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100mg*10 Capsules
- 150mg*10 Capsules
- 100mg*30 Capsules
- 150mg*30 Capsules
- 150mg*60 Capsules
- Locally Advanced NSCLC
- Variant NSCLC
- Locally Recurrent NSCLC
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim Pharma
What is the 10-year outlook for the global Nintedanib market?
What factors are driving Nintedanib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nintedanib market opportunities vary by end market size?
How does Nintedanib break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nintedanib Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Nintedanib by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Nintedanib by Country/Region, 2020, 2024 & 2031
2.2 Nintedanib Segment by Type
2.2.1 100mg*10 Capsules
2.2.2 150mg*10 Capsules
2.2.3 100mg*30 Capsules
2.2.4 150mg*30 Capsules
2.2.5 150mg*60 Capsules
2.3 Nintedanib Sales by Type
2.3.1 Global Nintedanib Sales Market Share by Type (2020-2025)
2.3.2 Global Nintedanib Revenue and Market Share by Type (2020-2025)
2.3.3 Global Nintedanib Sale Price by Type (2020-2025)
2.4 Nintedanib Segment by Application
2.4.1 Locally Advanced NSCLC
2.4.2 Variant NSCLC
2.4.3 Locally Recurrent NSCLC
2.5 Nintedanib Sales by Application
2.5.1 Global Nintedanib Sale Market Share by Application (2020-2025)
2.5.2 Global Nintedanib Revenue and Market Share by Application (2020-2025)
2.5.3 Global Nintedanib Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Nintedanib Breakdown Data by Company
3.1.1 Global Nintedanib Annual Sales by Company (2020-2025)
3.1.2 Global Nintedanib Sales Market Share by Company (2020-2025)
3.2 Global Nintedanib Annual Revenue by Company (2020-2025)
3.2.1 Global Nintedanib Revenue by Company (2020-2025)
3.2.2 Global Nintedanib Revenue Market Share by Company (2020-2025)
3.3 Global Nintedanib Sale Price by Company
3.4 Key Manufacturers Nintedanib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nintedanib Product Location Distribution
3.4.2 Players Nintedanib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NINTEDANIB BY GEOGRAPHIC REGION
4.1 World Historic Nintedanib Market Size by Geographic Region (2020-2025)
4.1.1 Global Nintedanib Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Nintedanib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nintedanib Market Size by Country/Region (2020-2025)
4.2.1 Global Nintedanib Annual Sales by Country/Region (2020-2025)
4.2.2 Global Nintedanib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nintedanib Sales Growth
4.4 APAC Nintedanib Sales Growth
4.5 Europe Nintedanib Sales Growth
4.6 Middle East & Africa Nintedanib Sales Growth
5 AMERICAS
5.1 Americas Nintedanib Sales by Country
5.1.1 Americas Nintedanib Sales by Country (2020-2025)
5.1.2 Americas Nintedanib Revenue by Country (2020-2025)
5.2 Americas Nintedanib Sales by Type (2020-2025)
5.3 Americas Nintedanib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nintedanib Sales by Region
6.1.1 APAC Nintedanib Sales by Region (2020-2025)
6.1.2 APAC Nintedanib Revenue by Region (2020-2025)
6.2 APAC Nintedanib Sales by Type (2020-2025)
6.3 APAC Nintedanib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nintedanib by Country
7.1.1 Europe Nintedanib Sales by Country (2020-2025)
7.1.2 Europe Nintedanib Revenue by Country (2020-2025)
7.2 Europe Nintedanib Sales by Type (2020-2025)
7.3 Europe Nintedanib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nintedanib by Country
8.1.1 Middle East & Africa Nintedanib Sales by Country (2020-2025)
8.1.2 Middle East & Africa Nintedanib Revenue by Country (2020-2025)
8.2 Middle East & Africa Nintedanib Sales by Type (2020-2025)
8.3 Middle East & Africa Nintedanib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nintedanib
10.3 Manufacturing Process Analysis of Nintedanib
10.4 Industry Chain Structure of Nintedanib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nintedanib Distributors
11.3 Nintedanib Customer
12 WORLD FORECAST REVIEW FOR NINTEDANIB BY GEOGRAPHIC REGION
12.1 Global Nintedanib Market Size Forecast by Region
12.1.1 Global Nintedanib Forecast by Region (2026-2031)
12.1.2 Global Nintedanib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nintedanib Forecast by Type (2026-2031)
12.7 Global Nintedanib Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim Pharma
13.1.1 Boehringer Ingelheim Pharma Company Information
13.1.2 Boehringer Ingelheim Pharma Nintedanib Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Pharma Nintedanib Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Pharma Main Business Overview
13.1.5 Boehringer Ingelheim Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nintedanib Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Nintedanib by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Nintedanib by Country/Region, 2020, 2024 & 2031
2.2 Nintedanib Segment by Type
2.2.1 100mg*10 Capsules
2.2.2 150mg*10 Capsules
2.2.3 100mg*30 Capsules
2.2.4 150mg*30 Capsules
2.2.5 150mg*60 Capsules
2.3 Nintedanib Sales by Type
2.3.1 Global Nintedanib Sales Market Share by Type (2020-2025)
2.3.2 Global Nintedanib Revenue and Market Share by Type (2020-2025)
2.3.3 Global Nintedanib Sale Price by Type (2020-2025)
2.4 Nintedanib Segment by Application
2.4.1 Locally Advanced NSCLC
2.4.2 Variant NSCLC
2.4.3 Locally Recurrent NSCLC
2.5 Nintedanib Sales by Application
2.5.1 Global Nintedanib Sale Market Share by Application (2020-2025)
2.5.2 Global Nintedanib Revenue and Market Share by Application (2020-2025)
2.5.3 Global Nintedanib Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Nintedanib Breakdown Data by Company
3.1.1 Global Nintedanib Annual Sales by Company (2020-2025)
3.1.2 Global Nintedanib Sales Market Share by Company (2020-2025)
3.2 Global Nintedanib Annual Revenue by Company (2020-2025)
3.2.1 Global Nintedanib Revenue by Company (2020-2025)
3.2.2 Global Nintedanib Revenue Market Share by Company (2020-2025)
3.3 Global Nintedanib Sale Price by Company
3.4 Key Manufacturers Nintedanib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nintedanib Product Location Distribution
3.4.2 Players Nintedanib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NINTEDANIB BY GEOGRAPHIC REGION
4.1 World Historic Nintedanib Market Size by Geographic Region (2020-2025)
4.1.1 Global Nintedanib Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Nintedanib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nintedanib Market Size by Country/Region (2020-2025)
4.2.1 Global Nintedanib Annual Sales by Country/Region (2020-2025)
4.2.2 Global Nintedanib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nintedanib Sales Growth
4.4 APAC Nintedanib Sales Growth
4.5 Europe Nintedanib Sales Growth
4.6 Middle East & Africa Nintedanib Sales Growth
5 AMERICAS
5.1 Americas Nintedanib Sales by Country
5.1.1 Americas Nintedanib Sales by Country (2020-2025)
5.1.2 Americas Nintedanib Revenue by Country (2020-2025)
5.2 Americas Nintedanib Sales by Type (2020-2025)
5.3 Americas Nintedanib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nintedanib Sales by Region
6.1.1 APAC Nintedanib Sales by Region (2020-2025)
6.1.2 APAC Nintedanib Revenue by Region (2020-2025)
6.2 APAC Nintedanib Sales by Type (2020-2025)
6.3 APAC Nintedanib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nintedanib by Country
7.1.1 Europe Nintedanib Sales by Country (2020-2025)
7.1.2 Europe Nintedanib Revenue by Country (2020-2025)
7.2 Europe Nintedanib Sales by Type (2020-2025)
7.3 Europe Nintedanib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nintedanib by Country
8.1.1 Middle East & Africa Nintedanib Sales by Country (2020-2025)
8.1.2 Middle East & Africa Nintedanib Revenue by Country (2020-2025)
8.2 Middle East & Africa Nintedanib Sales by Type (2020-2025)
8.3 Middle East & Africa Nintedanib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nintedanib
10.3 Manufacturing Process Analysis of Nintedanib
10.4 Industry Chain Structure of Nintedanib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nintedanib Distributors
11.3 Nintedanib Customer
12 WORLD FORECAST REVIEW FOR NINTEDANIB BY GEOGRAPHIC REGION
12.1 Global Nintedanib Market Size Forecast by Region
12.1.1 Global Nintedanib Forecast by Region (2026-2031)
12.1.2 Global Nintedanib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nintedanib Forecast by Type (2026-2031)
12.7 Global Nintedanib Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim Pharma
13.1.1 Boehringer Ingelheim Pharma Company Information
13.1.2 Boehringer Ingelheim Pharma Nintedanib Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Pharma Nintedanib Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Pharma Main Business Overview
13.1.5 Boehringer Ingelheim Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nintedanib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Nintedanib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg*10 Capsules
Table 4. Major Players of 150mg*10 Capsules
Table 5. Major Players of 100mg*30 Capsules
Table 6. Major Players of 150mg*30 Capsules
Table 7. Major Players of 150mg*60 Capsules
Table 8. Global Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Nintedanib Sales Market Share by Type (2020-2025)
Table 10. Global Nintedanib Revenue by Type (2020-2025) & ($ million)
Table 11. Global Nintedanib Revenue Market Share by Type (2020-2025)
Table 12. Global Nintedanib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Nintedanib Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Nintedanib Sale Market Share by Application (2020-2025)
Table 15. Global Nintedanib Revenue by Application (2020-2025) & ($ million)
Table 16. Global Nintedanib Revenue Market Share by Application (2020-2025)
Table 17. Global Nintedanib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Nintedanib Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Nintedanib Sales Market Share by Company (2020-2025)
Table 20. Global Nintedanib Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Nintedanib Revenue Market Share by Company (2020-2025)
Table 22. Global Nintedanib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Nintedanib Producing Area Distribution and Sales Area
Table 24. Players Nintedanib Products Offered
Table 25. Nintedanib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Nintedanib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Nintedanib Sales Market Share Geographic Region (2020-2025)
Table 30. Global Nintedanib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Nintedanib Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Nintedanib Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Nintedanib Sales Market Share by Country/Region (2020-2025)
Table 34. Global Nintedanib Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Nintedanib Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Nintedanib Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Nintedanib Sales Market Share by Country (2020-2025)
Table 38. Americas Nintedanib Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Nintedanib Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Nintedanib Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Nintedanib Sales Market Share by Region (2020-2025)
Table 43. APAC Nintedanib Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Nintedanib Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Nintedanib Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Nintedanib Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Nintedanib Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Nintedanib Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Nintedanib Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Nintedanib Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Nintedanib
Table 55. Key Market Challenges & Risks of Nintedanib
Table 56. Key Industry Trends of Nintedanib
Table 57. Nintedanib Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Nintedanib Distributors List
Table 60. Nintedanib Customer List
Table 61. Global Nintedanib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Nintedanib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Nintedanib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Nintedanib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Nintedanib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Nintedanib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Nintedanib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Nintedanib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Nintedanib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Nintedanib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Nintedanib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Nintedanib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Nintedanib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Nintedanib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Boehringer Ingelheim Pharma Basic Information, Nintedanib Manufacturing Base, Sales Area and Its Competitors
Table 76. Boehringer Ingelheim Pharma Nintedanib Product Portfolios and Specifications
Table 77. Boehringer Ingelheim Pharma Nintedanib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Boehringer Ingelheim Pharma Main Business
Table 79. Boehringer Ingelheim Pharma Latest Developments
Table 1. Nintedanib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Nintedanib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg*10 Capsules
Table 4. Major Players of 150mg*10 Capsules
Table 5. Major Players of 100mg*30 Capsules
Table 6. Major Players of 150mg*30 Capsules
Table 7. Major Players of 150mg*60 Capsules
Table 8. Global Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Nintedanib Sales Market Share by Type (2020-2025)
Table 10. Global Nintedanib Revenue by Type (2020-2025) & ($ million)
Table 11. Global Nintedanib Revenue Market Share by Type (2020-2025)
Table 12. Global Nintedanib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Nintedanib Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Nintedanib Sale Market Share by Application (2020-2025)
Table 15. Global Nintedanib Revenue by Application (2020-2025) & ($ million)
Table 16. Global Nintedanib Revenue Market Share by Application (2020-2025)
Table 17. Global Nintedanib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Nintedanib Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Nintedanib Sales Market Share by Company (2020-2025)
Table 20. Global Nintedanib Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Nintedanib Revenue Market Share by Company (2020-2025)
Table 22. Global Nintedanib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Nintedanib Producing Area Distribution and Sales Area
Table 24. Players Nintedanib Products Offered
Table 25. Nintedanib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Nintedanib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Nintedanib Sales Market Share Geographic Region (2020-2025)
Table 30. Global Nintedanib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Nintedanib Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Nintedanib Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Nintedanib Sales Market Share by Country/Region (2020-2025)
Table 34. Global Nintedanib Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Nintedanib Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Nintedanib Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Nintedanib Sales Market Share by Country (2020-2025)
Table 38. Americas Nintedanib Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Nintedanib Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Nintedanib Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Nintedanib Sales Market Share by Region (2020-2025)
Table 43. APAC Nintedanib Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Nintedanib Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Nintedanib Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Nintedanib Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Nintedanib Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Nintedanib Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Nintedanib Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Nintedanib Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Nintedanib Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Nintedanib
Table 55. Key Market Challenges & Risks of Nintedanib
Table 56. Key Industry Trends of Nintedanib
Table 57. Nintedanib Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Nintedanib Distributors List
Table 60. Nintedanib Customer List
Table 61. Global Nintedanib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Nintedanib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Nintedanib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Nintedanib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Nintedanib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Nintedanib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Nintedanib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Nintedanib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Nintedanib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Nintedanib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Nintedanib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Nintedanib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Nintedanib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Nintedanib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Boehringer Ingelheim Pharma Basic Information, Nintedanib Manufacturing Base, Sales Area and Its Competitors
Table 76. Boehringer Ingelheim Pharma Nintedanib Product Portfolios and Specifications
Table 77. Boehringer Ingelheim Pharma Nintedanib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Boehringer Ingelheim Pharma Main Business
Table 79. Boehringer Ingelheim Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nintedanib
Figure 2. Nintedanib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nintedanib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Nintedanib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Nintedanib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Nintedanib Sales Market Share by Country/Region (2024)
Figure 10. Nintedanib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg*10 Capsules
Figure 12. Product Picture of 150mg*10 Capsules
Figure 13. Product Picture of 100mg*30 Capsules
Figure 14. Product Picture of 150mg*30 Capsules
Figure 15. Product Picture of 150mg*60 Capsules
Figure 16. Global Nintedanib Sales Market Share by Type in 2025
Figure 17. Global Nintedanib Revenue Market Share by Type (2020-2025)
Figure 18. Nintedanib Consumed in Locally Advanced NSCLC
Figure 19. Global Nintedanib Market: Locally Advanced NSCLC (2020-2025) & (K Pcs)
Figure 20. Nintedanib Consumed in Variant NSCLC
Figure 21. Global Nintedanib Market: Variant NSCLC (2020-2025) & (K Pcs)
Figure 22. Nintedanib Consumed in Locally Recurrent NSCLC
Figure 23. Global Nintedanib Market: Locally Recurrent NSCLC (2020-2025) & (K Pcs)
Figure 24. Global Nintedanib Sale Market Share by Application (2024)
Figure 25. Global Nintedanib Revenue Market Share by Application in 2025
Figure 26. Nintedanib Sales by Company in 2025 (K Pcs)
Figure 27. Global Nintedanib Sales Market Share by Company in 2025
Figure 28. Nintedanib Revenue by Company in 2025 ($ millions)
Figure 29. Global Nintedanib Revenue Market Share by Company in 2025
Figure 30. Global Nintedanib Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Nintedanib Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Nintedanib Sales 2020-2025 (K Pcs)
Figure 33. Americas Nintedanib Revenue 2020-2025 ($ millions)
Figure 34. APAC Nintedanib Sales 2020-2025 (K Pcs)
Figure 35. APAC Nintedanib Revenue 2020-2025 ($ millions)
Figure 36. Europe Nintedanib Sales 2020-2025 (K Pcs)
Figure 37. Europe Nintedanib Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Nintedanib Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Nintedanib Revenue 2020-2025 ($ millions)
Figure 40. Americas Nintedanib Sales Market Share by Country in 2025
Figure 41. Americas Nintedanib Revenue Market Share by Country (2020-2025)
Figure 42. Americas Nintedanib Sales Market Share by Type (2020-2025)
Figure 43. Americas Nintedanib Sales Market Share by Application (2020-2025)
Figure 44. United States Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Nintedanib Sales Market Share by Region in 2025
Figure 49. APAC Nintedanib Revenue Market Share by Region (2020-2025)
Figure 50. APAC Nintedanib Sales Market Share by Type (2020-2025)
Figure 51. APAC Nintedanib Sales Market Share by Application (2020-2025)
Figure 52. China Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 56. India Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Nintedanib Sales Market Share by Country in 2025
Figure 60. Europe Nintedanib Revenue Market Share by Country (2020-2025)
Figure 61. Europe Nintedanib Sales Market Share by Type (2020-2025)
Figure 62. Europe Nintedanib Sales Market Share by Application (2020-2025)
Figure 63. Germany Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 64. France Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Nintedanib Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Nintedanib Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Nintedanib Sales Market Share by Application (2020-2025)
Figure 71. Egypt Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Nintedanib in 2025
Figure 77. Manufacturing Process Analysis of Nintedanib
Figure 78. Industry Chain Structure of Nintedanib
Figure 79. Channels of Distribution
Figure 80. Global Nintedanib Sales Market Forecast by Region (2026-2031)
Figure 81. Global Nintedanib Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Nintedanib Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Nintedanib Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Nintedanib Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Nintedanib Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Nintedanib
Figure 2. Nintedanib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nintedanib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Nintedanib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Nintedanib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Nintedanib Sales Market Share by Country/Region (2024)
Figure 10. Nintedanib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg*10 Capsules
Figure 12. Product Picture of 150mg*10 Capsules
Figure 13. Product Picture of 100mg*30 Capsules
Figure 14. Product Picture of 150mg*30 Capsules
Figure 15. Product Picture of 150mg*60 Capsules
Figure 16. Global Nintedanib Sales Market Share by Type in 2025
Figure 17. Global Nintedanib Revenue Market Share by Type (2020-2025)
Figure 18. Nintedanib Consumed in Locally Advanced NSCLC
Figure 19. Global Nintedanib Market: Locally Advanced NSCLC (2020-2025) & (K Pcs)
Figure 20. Nintedanib Consumed in Variant NSCLC
Figure 21. Global Nintedanib Market: Variant NSCLC (2020-2025) & (K Pcs)
Figure 22. Nintedanib Consumed in Locally Recurrent NSCLC
Figure 23. Global Nintedanib Market: Locally Recurrent NSCLC (2020-2025) & (K Pcs)
Figure 24. Global Nintedanib Sale Market Share by Application (2024)
Figure 25. Global Nintedanib Revenue Market Share by Application in 2025
Figure 26. Nintedanib Sales by Company in 2025 (K Pcs)
Figure 27. Global Nintedanib Sales Market Share by Company in 2025
Figure 28. Nintedanib Revenue by Company in 2025 ($ millions)
Figure 29. Global Nintedanib Revenue Market Share by Company in 2025
Figure 30. Global Nintedanib Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Nintedanib Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Nintedanib Sales 2020-2025 (K Pcs)
Figure 33. Americas Nintedanib Revenue 2020-2025 ($ millions)
Figure 34. APAC Nintedanib Sales 2020-2025 (K Pcs)
Figure 35. APAC Nintedanib Revenue 2020-2025 ($ millions)
Figure 36. Europe Nintedanib Sales 2020-2025 (K Pcs)
Figure 37. Europe Nintedanib Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Nintedanib Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Nintedanib Revenue 2020-2025 ($ millions)
Figure 40. Americas Nintedanib Sales Market Share by Country in 2025
Figure 41. Americas Nintedanib Revenue Market Share by Country (2020-2025)
Figure 42. Americas Nintedanib Sales Market Share by Type (2020-2025)
Figure 43. Americas Nintedanib Sales Market Share by Application (2020-2025)
Figure 44. United States Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Nintedanib Sales Market Share by Region in 2025
Figure 49. APAC Nintedanib Revenue Market Share by Region (2020-2025)
Figure 50. APAC Nintedanib Sales Market Share by Type (2020-2025)
Figure 51. APAC Nintedanib Sales Market Share by Application (2020-2025)
Figure 52. China Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 56. India Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Nintedanib Sales Market Share by Country in 2025
Figure 60. Europe Nintedanib Revenue Market Share by Country (2020-2025)
Figure 61. Europe Nintedanib Sales Market Share by Type (2020-2025)
Figure 62. Europe Nintedanib Sales Market Share by Application (2020-2025)
Figure 63. Germany Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 64. France Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Nintedanib Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Nintedanib Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Nintedanib Sales Market Share by Application (2020-2025)
Figure 71. Egypt Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Nintedanib Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Nintedanib in 2025
Figure 77. Manufacturing Process Analysis of Nintedanib
Figure 78. Industry Chain Structure of Nintedanib
Figure 79. Channels of Distribution
Figure 80. Global Nintedanib Sales Market Forecast by Region (2026-2031)
Figure 81. Global Nintedanib Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Nintedanib Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Nintedanib Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Nintedanib Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Nintedanib Revenue Market Share Forecast by Application (2026-2031)
